# Oruka Therapeutics, Inc.: Form DEF 14A, filed Oct 18, 2024

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: DEF 14A
- Filed: 2024-10-18
- Accepted by EDGAR: Oct 18, 2024, 16:11 ET
- Period: 2024-11-14
- Accession: 0001140361-24-043698
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000114036124043698/ny20036093x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000114036124043698/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000114036124043698/ny20036093x2_def14a.htm

Filed Oct 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-043698. Last ingested by Listed: Nov 10, 2026, 01:43 ET. No prices; not investment advice.